Bhaskar Rao Vamsi Krishna Velaga
Directeur/Membre du Conseil chez Cronus Pharma Specialities India Pvt Ltd.
Postes actifs de Bhaskar Rao Vamsi Krishna Velaga
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cronus Pharma Specialities India Pvt Ltd.
 Cronus Pharma Specialities India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Cronus Pharma Specialities India Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hyderabad, India and was founded in 2015. | Directeur/Membre du Conseil | 16/02/2019 | - |
Casper Pharma Pvt Ltd.
 Casper Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Suven Pharmaceuticals Ltd., Casper Pharma Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The company is based in Hyderabad, India. The company was founded in 2016. Casper Pharma was acquired by Suven Pharmaceuticals Ltd. on June 30, 2022 for $20.75 million. | Directeur/Membre du Conseil | 16/02/2019 | - |
Historique de carrière de Bhaskar Rao Vamsi Krishna Velaga
Statistiques
Internationale
| Inde | 3 |
Opérationnelle
| Director/Board Member | 2 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cronus Pharma Specialities India Pvt Ltd.
Cronus Pharma Specialities India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Cronus Pharma Specialities India Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hyderabad, India and was founded in 2015. | Health Technology |
Casper Pharma Pvt Ltd.
Casper Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Suven Pharmaceuticals Ltd., Casper Pharma Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The company is based in Hyderabad, India. The company was founded in 2016. Casper Pharma was acquired by Suven Pharmaceuticals Ltd. on June 30, 2022 for $20.75 million. | Health Technology |
